Daito Pharmaceutical Co.,Ltd. (TYO:4577)

Market Cap	39.72B
Revenue (ttm)	51.20B
Net Income (ttm)	2.23B
Shares Out	29.47M
EPS (ttm)	74.32
PE Ratio	18.14
Forward PE	16.90
Dividend	40.00 (2.98%)
Ex-Dividend Date	May 28, 2026

Volume	72,200
Average Volume	79,450
Open	1,344.00
Previous Close	1,344.00
Day's Range	1,342.00 - 1,354.00
52-Week Range	970.00 - 1,382.00
Beta	0.25
RSI	53.28
Earnings Date	Jan 14, 2026

About Daito Pharmaceutical

Daito Pharmaceutical Co.,Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs. The company is also involved in the wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries. The company was formerly known as Daito Corporation and changed its nam...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1942
• Employees: 1,073
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4577

Financial Performance

In 2025, Daito Pharmaceutical's revenue was 50.64 billion, an increase of 7.99% compared to the previous year's 46.90 billion. Earnings were 1.91 billion, a decrease of -42.09%.